Karlan BY - Search Results

1

Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment.

Taylor-Harding B, Agadjanian H, Nassanian H, Kwon S, Guo X, Miller C, Karlan BY, Orsulic S, Walsh CS. Taylor-Harding B, et al. Among authors: karlan by. Br J Cancer. 2012 Jan 17;106(2):333-43. doi: 10.1038/bjc.2011.546. Epub 2011 Dec 13. Br J Cancer. 2012. PMID: 22166800 Free PMC article.

2

Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.

Bristow RE, Baldwin RL, Yamada SD, Korc M, Karlan BY. Bristow RE, et al. Among authors: karlan by. Cancer. 1999 Feb 1;85(3):658-68. doi: 10.1002/(sici)1097-0142(19990201)85:3<658::aid-cncr16>3.0.co;2-m. Cancer. 1999. PMID: 10091739

3

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

4

Differential gene expression between normal and tumor-derived ovarian epithelial cells.

Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC, Chang DD. Ismail RS, et al. Among authors: karlan by. Cancer Res. 2000 Dec 1;60(23):6744-9. Cancer Res. 2000. PMID: 11118061

5

Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.

Baldwin RL, Tran H, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Cancer Res. 2003 Mar 15;63(6):1413-9. Cancer Res. 2003. PMID: 12649207

6

Improved survival in women with BRCA-associated ovarian carcinoma.

Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY. Cass I, et al. Among authors: karlan by. Cancer. 2003 May 1;97(9):2187-95. doi: 10.1002/cncr.11310. Cancer. 2003. PMID: 12712470 Free article.

7

Coexisting ovarian malignancy in young women with endometrial cancer.

Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Walsh C, et al. Obstet Gynecol. 2005 Oct;106(4):693-9. doi: 10.1097/01.AOG.0000172423.64995.6f. Obstet Gynecol. 2005. PMID: 16199623

8

The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.

Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ. Lerner DL, et al. Among authors: karlan by. Gynecol Oncol. 2007 Jan;104(1):91-4. doi: 10.1016/j.ygyno.2006.07.020. Epub 2006 Aug 24. Gynecol Oncol. 2007. PMID: 16934317

9

Effect of obesity on survival in epithelial ovarian cancer.

Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Li AJ. Pavelka JC, et al. Among authors: karlan by. Cancer. 2006 Oct 1;107(7):1520-4. doi: 10.1002/cncr.22194. Cancer. 2006. PMID: 16941453 Free article.

10

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

Walsh CS, Miller CW, Karlan BY, Koeffler HP. Walsh CS, et al. Among authors: karlan by. Gynecol Oncol. 2007 Mar;104(3):660-4. doi: 10.1016/j.ygyno.2006.10.008. Epub 2006 Nov 21. Gynecol Oncol. 2007. PMID: 17123590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

521 results

Search Page

Filters